Rotigotine adverse effects affecting patient's sexual partner

Area of Science:

• Neuropharmacology
• Reproductive Biology

Background:

• Rotigotine is a dopaminergic agonist commonly used for Parkinson disease.
• Somnolence is a known adverse effect of rotigotine treatment.

Observation:

• A spouse of a male patient with advanced Parkinson disease experienced adverse effects.
• The spouse's symptoms, including somnolence, resolved after protected sexual intercourse.

Findings:

• The study proposes exposure to rotigotine through seminal fluid as a potential cause of the spouse's symptoms.
• This suggests a previously unrecognized mechanism of drug transfer and adverse effects.

Implications:

• This mechanism may be more common than previously thought.
• Other psychoactive compounds crossing the blood-testis barrier could potentially cause similar effects.
• This could explain otherwise unexplained cases of postcoital somnolence or fatigue.